{"title":"Trisomy 21 in neoplastic cells.","authors":"F Mitelman, S Heim, N Mandahl","doi":"10.1002/ajmg.1320370752","DOIUrl":"https://doi.org/10.1002/ajmg.1320370752","url":null,"abstract":"<p><p>Trisomy 21 as an acquired clonal chromosome change has been described in 642 of the 10,625 human neoplasms with chromosome aberrations known from the cytogenetic literature. A total of 590 of the 642 cases (92%) are hematologic disorders and malignant lymphomas. The incidence of trisomy 21 is similar (4.1%-6.7%) in acute myeloid leukemia (AML), chronic myeloid leukemia, myeloproliferative disorders, myelodysplastic syndromes, chronic lymphoproliferative disorders, and malignant lymphomas; it is substantially higher (14.8%) in acute lymphocytic leukemia (ALL). In most cases, the extra chromosome 21 is present together with other numerical and/or structural changes. Acquired trisomy 21 is the only karyotypic abnormality in only 0.4%. Trisomy 21 has never been reported as the sole anomaly in a solid tumor. The cytogenetic literature contains information on 62 patients with constitutional trisomy 21 and a malignant disorder in which the tumor cells have been analyzed by banding techniques. Thirty-four of the 62 patients had AML, 16 had ALL, and 2 had acute undifferentiated leukemia. The 52 leukemic Down syndrome (DS) cases account for 1.4% of the total acute leukemias, an overrepresentation that parallels the generally increased risk of leukemia development in DS. Sixty-three percent of the ALL patients and 79% of those with AML had additional changes superimposed on constitutional trisomy 21. These included several of the characteristic primary leukemia-associated aberrations: 5q-, 7q-, +8, and t(8;21) in AML, and t(1;19), t(4;11), 6q-, and 14q + in ALL. Thus, it seems that the pattern of acquired karyotypic changes is similar in patients with DS and in individuals with a normal constitutional karyotype.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"262-6"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370752","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Distribution of X-ray-induced chromosome breakpoints in Down syndrome lymphocytes.","authors":"H M Shafik, W W Au, E B Whorton, M S Legator","doi":"10.1002/ajmg.1320370740","DOIUrl":"https://doi.org/10.1002/ajmg.1320370740","url":null,"abstract":"<p><p>Down syndrome (DS) individuals are known to be predisposed to develop leukemia and their lymphocytes are highly sensitive to the induction of chromosome aberrations by X-rays. A study was conducted to identify the chromosome breakpoints and to evaluate whether site specificity for chromosome breakage and rearrangement may exist which may explain the predisposition phenomenon. DS lymphocytes at the G1 phase of the cell cycle were irradiated with 300, 450, and 600 rad of X-rays. Cells were harvested after 3 days in culture and 193 G-banded karyotypes were analyzed to identify the induced chromosome abnormalities. Out of 273 breakpoints identified, 122 were involved in the formation of stable chromosome rearrangements and 151 in the formation of unstable abnormalities. The Poisson analysis of these breakpoints demonstrated that 16 chromosome bands located in chromosomes 1, 3, 7, 12, 17, 19 and X were preferentially involved in breakage and rearrangement (P less than 0.05). These 16 bands are also found to be locations of \"cancer breakpoints,\" oncogenes, or fragile sites. Many abnormal cells were observed to carry stable chromosome rearrangements only. Therefore, these cells are presumed to be compatible with survival and to be \"initiated\" in the transformation process. We propose that similar stable and site-specific chromosome rearrangements may exist in proliferating cells in DS individuals after exposure to clastogens and that this abnormality predisposes them to develop leukemia.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"195-200"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370740","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13303556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R T Zori, D A Schatz, H Ostrer, C A Williams, R Spillar, W J Riley
{"title":"Relationship of autoimmunity to thyroid dysfunction in children and adults with Down syndrome.","authors":"R T Zori, D A Schatz, H Ostrer, C A Williams, R Spillar, W J Riley","doi":"10.1002/ajmg.1320370748","DOIUrl":"https://doi.org/10.1002/ajmg.1320370748","url":null,"abstract":"<p><p>The extent to which autoimmunity contributes to thyroid dysfunction in Down Syndrome (DS) individuals has not been clarified. We studied 61 persons (34 males and 27 females) with DS (age 5 months to 48 years) for the presence of thyroid autoantibodies (thyroid microsomal antibodies and thyroglobulin antibodies), pancreatic islet cell autoantibodies, gastric parietal cell autoantibodies, and adrenocortical autoantibodies. Thyroid function was determined by measurement of TSH. HLA-A, B and -DR typing was performed on 52 subjects. Forty of 61 subjects (66%) had thyroid dysfunction: elevated TSH values (greater than 5 mcIU/ml) were found in 35 of 61 individuals; 3 subjects had previously documented Hashimoto thyroiditis and were on therapy for hyperthyroidism; and 2 persons had Graves disease. No age or sex variation was detected. Seventeen (28%) subjects had thyroid autoantibodies. Fifteen of the 17 had thyroid dysfunction. Twelve of 25 subjects (48%) over 10 years with thyroid dysfunction had thyroid autoantibodies compared to only 3 of 15 (20%) under the age of 10 years. However, children less than of 10 years tended to have higher TSH values. Only 1 individual who had thyroid antibodies had gastric parietal cell autoantibodies present. Islet cell and adrenocortical autoantibodies were not found in any individuals. Neither thyroid dysfunction nor thyroid autoantibodies correlated with any HLA allele. These findings suggest that thyroid dysfunction in individuals with DS of all ages is a common heterogeneous disorder which cannot be solely explained on the basis of autoimmunity. We recommend that thyroid function be followed closely whether or not thyroid autoantibodies are present.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"238-41"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370748","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Down syndrome children and their families.","authors":"A Gath","doi":"10.1002/ajmg.1320370762","DOIUrl":"https://doi.org/10.1002/ajmg.1320370762","url":null,"abstract":"<p><p>The philosophy of community care means that responsibility for the care of children with Down syndrome (DS) remains still more firmly with the families. Demographic changes have made the typical DS family of the 1970s and 1980s differ in structure, size, and status from that typical of earlier decades. The findings of a population study of DS children and their families, matched with children with a similar degree of mental retardation, and of a longitudinal study of DS children born 1970-1972, are discussed in relation to a series of similar studies. From these results it is possible to identify vulnerable families for appropriate help.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"314-6"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370762","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G Palka, M Ciccotelli, G Sabatino, G Calabrese, P Guanciali Franchi, L Stuppia, G Parruti, C Di Virgilio, O Di Sante
{"title":"Cytogenetic study of the heterochromatic polymorphisms in 100 subjects with Down syndrome and their parents.","authors":"G Palka, M Ciccotelli, G Sabatino, G Calabrese, P Guanciali Franchi, L Stuppia, G Parruti, C Di Virgilio, O Di Sante","doi":"10.1002/ajmg.1320370741","DOIUrl":"https://doi.org/10.1002/ajmg.1320370741","url":null,"abstract":"<p><p>We report on a cytogenetic study of 100 subjects with Down syndrome (DS), diagnosed from 1980 to 1988, and their parents. Free trisomy was present in 95% of the patients; 5% had trisomy due to an unbalanced translocation. Approximately 60% of patients were born to mothers younger than age 35 years, the highest number of DS births being in the group of mothers between ages 25 and 29 years. These findings are clearly related to the higher number of pregnancies in this group. However, the prevalence of DS births increased significantly in women older than age 35 years, as expected. A cytogenetic study of heterochromatic polymorphisms showed a significant increase of polymorphisms in DS children and in their parents, mostly in mothers, compared with a control group. Since heterochromatic blocks of acrocentric and nonacrocentric chromosomes are frequently associated during interphase, we discuss a possible correlation between nondisjunction and heterochromatic polymorphism.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"201-3"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370741","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Franceschi, M Comola, F Piattoni, W Gualandri, N Canal
{"title":"Prevalence of dementia in adult patients with trisomy 21.","authors":"M Franceschi, M Comola, F Piattoni, W Gualandri, N Canal","doi":"10.1002/ajmg.1320370760","DOIUrl":"https://doi.org/10.1002/ajmg.1320370760","url":null,"abstract":"<p><p>Neuropathological lesions characteristic of Alzheimer's disease (AD) are found in all the brains of patients with trisomy 21 who die after age 40 years. However, clinical signs of AD are much less frequent in these patients. Previous studies indicate prevalence figures ranging from 15% to 51% of adult patients. We report here on the prevalence rate of dementia in a population of adult patients with trisomy 21 with mild retardation living at home. For all these patients accurate and reliable anamnestic data could be obtained from parents and caregivers. All underwent neurological examination, cognitive testing, and, if necessary, further bioimaging and neurophysiological studies. Dementia was diagnosed according to clinical NINCDS/ADRDA criteria slightly modified. Dementia was found in 9 of 50 (18%) patients age 20-52 years, but its prevalence increased from 0 in the age group 20-29, to 33% in the age group 30-39, and to 55% in the age group 40-52. All the demented patients had signs of brain atrophy on CT scans and slow EEGs. Dementia is an important problem for patients with trisomy 21 older than age 30 years.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"306-8"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370760","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is the cultural approach toward Down syndrome people changing?","authors":"C Inglese","doi":"10.1002/ajmg.1320370764","DOIUrl":"https://doi.org/10.1002/ajmg.1320370764","url":null,"abstract":"","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"322-3"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370764","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rubinstein-Taybi syndrome. Papers presented at the 9th annual David W. Smith Workshop on Malformations and Morphogenesis. Oakland, 1988. Proceedings.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"6 ","pages":"1-131"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13273905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G W Dewald, J L Diez-Martin, S L Steffen, R B Jenkins, P J Stupca, E O Burgert
{"title":"Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.","authors":"G W Dewald, J L Diez-Martin, S L Steffen, R B Jenkins, P J Stupca, E O Burgert","doi":"10.1002/ajmg.1320370750","DOIUrl":"https://doi.org/10.1002/ajmg.1320370750","url":null,"abstract":"<p><p>To study the role of trisomy 21 in hematologic malignancies, we investigated the hematologic disorders of 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome (DS). The most common hematologic malignancy among the patients with acquired trisomy 21 involved both granulocytic and monocytic lineages. By comparison, the hematologic disorders among the DS patients were predominantly acute lymphocytic leukemia and acute megakaryocytic leukemia. Although our sample was small, our results suggest that most patients with acquired trisomy 21 have different hematologic disorders than individuals with DS. Perhaps the role of trisomy 21 in the development of hematologic malignancy is different in constitutional trisomy 21 than it is in acquired trisomy 21.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"247-50"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370750","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D K Kalwinsky, S C Raimondi, N J Bunin, D Fairclough, C H Pui, M V Relling, R Ribeiro, G K Rivera
{"title":"Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.","authors":"D K Kalwinsky, S C Raimondi, N J Bunin, D Fairclough, C H Pui, M V Relling, R Ribeiro, G K Rivera","doi":"10.1002/ajmg.1320370753","DOIUrl":"https://doi.org/10.1002/ajmg.1320370753","url":null,"abstract":"<p><p>Twenty-eight children with Down syndrome (DS) and acute lymphocytic leukemia (ALL) were compared to non-DS control leukemics matched by age, white blood cell (WBC) count, and treatment protocol to evaluate presenting manifestations, toxicity, and outcome. The DS children with ALL did not have unique clinical or biologic characteristics to distinguish their disease from that of non-DS patients. Eleven of the DS patients had successfully banded cytogenetic studies of their leukemic cells with the distribution of model chromosome number of 46 (n = 1), 47 (2), 48 (5), and greater than 50 (3). The abnormal leukemic line involved an isochromosome of the long arm of chromosome 9[i(9q)] in 3 cases. Multiagent chemotherapies induced complete remissions in 25 patients (85%), yet overall 5 year event-free survival was only 23 +/- 8% when compared to 64 +/- 9% for control children receiving similar therapies (P less than 0.01). A significant cause of treatment failure was late marrow recurrence in the DS children. Host toxicity was striking in these children. Severe congenital heart disease present in one-third contributed to 2 deaths during antileukemia therapy. Hyperglycemia secondary to diabetogenic agents and repeated bronchitis were common toxicities. Intolerance to the antifolate methotrexate with severe gastrointestinal and skin toxicities was universal. We conclude that the poor prognosis for the child with DS and ALL stems in part from their increased risk of complications and toxicity from intensive modern leukemia therapies, specifically antifolates.</p>","PeriodicalId":77486,"journal":{"name":"American journal of medical genetics. Supplement","volume":"7 ","pages":"267-71"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ajmg.1320370753","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13304728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}